191 related articles for article (PubMed ID: 35987412)
1. Fufang Zhenzhu Tiaozhi capsule ameliorates hyperuricemic nephropathy by inhibition of PI3K/AKT/NF-κB pathway.
Li MH; Guan J; Chen Z; Mo JX; Wu KR; Hu XG; Lan T; Guo J
J Ethnopharmacol; 2022 Nov; 298():115644. PubMed ID: 35987412
[TBL] [Abstract][Full Text] [Related]
2. Baicalin and baicalein attenuate hyperuricemic nephropathy via inhibiting PI3K/AKT/NF-κB signalling pathway.
Liu Z; Xiang H; Deng Q; Fu W; Li Y; Yu Z; Qiu Y; Mei Z; Xu L
Nephrology (Carlton); 2023 Jun; 28(6):315-327. PubMed ID: 36974463
[TBL] [Abstract][Full Text] [Related]
3. Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling.
Ren Q; Tao S; Guo F; Wang B; Yang L; Ma L; Fu P
Phytomedicine; 2021 Jul; 87():153552. PubMed ID: 33994251
[TBL] [Abstract][Full Text] [Related]
4. Xanthoceras sorbifolium leaves alleviate hyperuricemic nephropathy by inhibiting the PI3K/AKT signaling pathway to regulate uric acid transport.
Liu Y; Han Y; Liu Y; Huang C; Feng W; Cui H; Li M
J Ethnopharmacol; 2024 Jun; 327():117946. PubMed ID: 38447615
[TBL] [Abstract][Full Text] [Related]
5. Naringenin Ameliorates Hyperuricemia by Regulating Renal Uric Acid Excretion via the PI3K/AKT Signaling Pathway and Renal Inflammation through the NF-κB Signaling Pathway.
Yang B; Xin M; Liang S; Huang Y; Li J; Wang C; Liu C; Song X; Sun J; Sun W
J Agric Food Chem; 2023 Jan; 71(3):1434-1446. PubMed ID: 36525382
[TBL] [Abstract][Full Text] [Related]
6. Ethanol extract of Liriodendron chinense (Hemsl.) Sarg barks attenuates hyperuricemic nephropathy by inhibiting renal fibrosis and inflammation in mice.
Pan J; Zhang C; Shi M; Guo F; Liu J; Li L; Ren Q; Tao S; Tang M; Ye H; Ma L; Fu P
J Ethnopharmacol; 2021 Jan; 264():113278. PubMed ID: 32841699
[TBL] [Abstract][Full Text] [Related]
7. The Terminalia chebula Retz extract treats hyperuricemic nephropathy by inhibiting TLR4/MyD88/NF-κB axis.
Liu H; Chen Z; Liu M; Li E; Shen J; Wang J; Liu W; Jin X
J Ethnopharmacol; 2024 Mar; 322():117678. PubMed ID: 38159820
[TBL] [Abstract][Full Text] [Related]
8. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease.
Yang YQ; Tan HB; Zhang XY; Zhang YZ; Lin QY; Huang MY; Lin ZY; Mo JZ; Zhang Y; Lan T; Bei WJ; Guo J
J Ethnopharmacol; 2022 Jun; 292():115165. PubMed ID: 35247475
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
10. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.
Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J
Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255
[TBL] [Abstract][Full Text] [Related]
11. Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway.
Liu Y; Gong S; Li K; Wu G; Zheng X; Zheng J; Lu X; Zhang L; Li J; Su Z; Liu Y; Xie J; Chen J; Li Y
Biomed Pharmacother; 2022 Dec; 156():113941. PubMed ID: 36411660
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats.
Liu N; Xu L; Shi Y; Fang L; Gu H; Wang H; Ding X; Zhuang S
Oncotarget; 2017 May; 8(20):33807-33826. PubMed ID: 28442634
[TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese Medicine Fufang-Zhenzhu-Tiaozhi capsule prevents renal injury in diabetic minipigs with coronary heart disease.
Song L; Wang K; Yin J; Yang Y; Li B; Zhang D; Wang H; Wang W; Zhan W; Guo C; Gu Z; Wang L; Zeng Z; Bei W; Rong X; Guo J
Chin Med; 2022 Aug; 17(1):102. PubMed ID: 36042482
[TBL] [Abstract][Full Text] [Related]
14. Amelioration effects of α-viniferin on hyperuricemia and hyperuricemia-induced kidney injury in mice.
Guo XL; Gao YY; Yang YX; Zhu QF; Guan HY; He X; Zhang CL; Wang Y; Xu GB; Zou SH; Wei MC; Zhang J; Zhang JJ; Liao SG
Phytomedicine; 2023 Jul; 116():154868. PubMed ID: 37209608
[TBL] [Abstract][Full Text] [Related]
15. Piperine Improves Hyperuricemic Nephropathy by Inhibiting URAT1/GLUT9 and the AKT-mTOR Pathway.
Li L; Zhao K; Luo J; Tian J; Zheng F; Lin X; Xie Z; Jiang H; Li Y; Zhao Z; Wu T; Pang J
J Agric Food Chem; 2024 Mar; 72(12):6565-6574. PubMed ID: 38498316
[TBL] [Abstract][Full Text] [Related]
16. Chlorogenic Acid Prevents Hyperuricemia Nephropathy via Regulating TMAO-Related Gut Microbes and Inhibiting the PI3K/AKT/mTOR Pathway.
Zhou X; Zhang B; Zhao X; Lin Y; Zhuang Y; Guo J; Wang S
J Agric Food Chem; 2022 Aug; 70(33):10182-10193. PubMed ID: 35950815
[TBL] [Abstract][Full Text] [Related]
17. The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease.
Song L; Zhang D; Guo C; Gu Z; Wang L; Yao YS; Wang H; Zeng Z; Wang W; Yang Y; Bei W; Rong X; Guo J
Biomed Pharmacother; 2021 May; 137():111343. PubMed ID: 33761594
[TBL] [Abstract][Full Text] [Related]
18. Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways.
Lei L; Zhao J; Liu XQ; Chen J; Qi XM; Xia LL; Wu YG
Drug Des Devel Ther; 2021; 15():3131-3150. PubMed ID: 34295152
[TBL] [Abstract][Full Text] [Related]
19. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats.
Chen X; Ge HZ; Lei SS; Jiang ZT; Su J; He X; Zheng X; Wang HY; Yu QX; Li B; Lv GY; Chen SH
Biomed Pharmacother; 2020 Dec; 132():110765. PubMed ID: 33120237
[TBL] [Abstract][Full Text] [Related]
20. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway.
Diao H; Cheng J; Huang X; Huang B; Shao X; Zhao J; Lan D; Zhu Q; Yan M; Zhang Y; Rong X; Guo J
J Ethnopharmacol; 2022 Jul; 293():115261. PubMed ID: 35447198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
